Leap Therapeutics Inc. (LPTX)
NASDAQ: LPTX
· Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM
Leap Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -69.17M | -67.56M | -64.59M | -60.11M | -53.37M | -81.41M | -81.05M | -82.45M | -86.08M | -54.6M | -53.28M | -49.33M | -41.83M | -40.59M | -36.51M | -32.43M | -29.42M |
Depreciation & Amortization | n/a | 5K | 115K | 118K | 22K | 121K | 15K | 218K | 116K | 16K | 20K | 23K | -69K | 29K | -377K | -285K | -65K |
Stock-Based Compensation | 5.46M | 5.5M | 5.21M | 5.17M | 5.07M | 5.13M | 5.33M | 5.29M | 5.29M | 5.18M | 4.66M | 4.41M | 3.85M | 3.48M | 3.4M | 3.13M | 3.04M |
Other Working Capital | -2.74M | -3.17M | -4.67M | -2.08M | -2.13M | 497K | -330K | -1.63M | 226K | -1.82M | -4.05M | -1.11M | -2.29M | -3.27M | 1.84M | -30K | -3.6M |
Other Non-Cash Items | 3.9M | 7.91M | 7.03M | 3.77M | 4.07M | 29.9M | 29.59M | 30.18M | 30.82M | 855K | 1.77M | 930K | 320K | 485K | 338K | 312K | 121K |
Deferred Income Tax | n/a | n/a | -501K | n/a | n/a | n/a | 653K | 152K | 152K | 152K | 11K | 271K | 400K | 421K | 374K | -123K | -1.2M |
Change in Working Capital | 796K | -2.27M | 1.46M | 4.89M | 1.54M | 2.51M | -924K | -1.54M | -522K | -651K | 70K | 1.1M | -763K | 1.01M | 2.35M | 474K | -3.1M |
Operating Cash Flow | -59.26M | -60.3M | -55.17M | -50.05M | -46.57M | -43.75M | -46.39M | -48.15M | -50.23M | -49.04M | -46.75M | -42.59M | -38.09M | -35.16M | -30.43M | -28.92M | -30.62M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25K | 25K | 25K |
Cash Acquisitions | n/a | n/a | -100.72M | -100.72M | -50.36M | n/a | 100.72M | 100.72M | 50.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -50.71M | -51.76M | -51.76M | -51.76M | -1.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -100.72M | -100.72M | -101.07M | -51.76M | 49.18M | 49.18M | 49.53M | 210K | n/a | n/a | n/a | n/a | 25K | 25K | 50K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 13K | 13K | 13K | 13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 37.09M | 37.18M | 37.08M | 37.15M | 28K | -30K | -30K | -29K | -29K | -210K | 545K | 585K | 589K | 813K | -25.12M | -25.54M | -25.29M |
Financial Cash Flow | 37.09M | 37.18M | 37.08M | 37.15M | 28K | -30K | -30K | -29K | -29K | -210K | 545K | 97.81M | 97.81M | 98.03M | 23.28M | -74.36M | -25.59M |
Net Cash Flow | -22.21M | -23.39M | -17.92M | -12.94M | -47.12M | 5.14M | 2.44M | 532K | -1.18M | -49.42M | -46.46M | 55.15M | 59.73M | 62.84M | 66.8M | -29.15M | 18.03M |
Free Cash Flow | -59.26M | -60.3M | -55.17M | -50.05M | -46.57M | -43.75M | -46.39M | -48.15M | -50.23M | -49.04M | -46.75M | -42.59M | -38.09M | -35.16M | -30.4M | -28.89M | -30.59M |